Natural History and Spontaneous Prognostic Factors

Oct 25, 2017 by in ONCOLOGY Comments Off on Natural History and Spontaneous Prognostic Factors

Fully validated in clinical trials  • Age >40 years  • Presence of neurological deficits and/or absence of seizures at onset  • Low performance status (Karnofsky <70)  • Preoperative tumor diameter >4–6 cm  • Astrocytoma as…

read more

Quality of Life in Patients with Diffuse Low-Grade Glioma

Oct 25, 2017 by in ONCOLOGY Comments Off on Quality of Life in Patients with Diffuse Low-Grade Glioma

© Springer-Verlag London Ltd. 2017Hugues Duffau (ed.)Diffuse Low-Grade Gliomas in Adults10.1007/978-3-319-55466-2_13 13. Quality of Life in Patients with Diffuse Low-Grade Glioma Martin Klein1   (1) Department of Medical Psychology, VU University Medical Center, De Boelelaan 1118,…

read more

The Genomics of Diffuse Low-Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on The Genomics of Diffuse Low-Grade Gliomas

Molecular markers Prevalence (n > 1000 glioma subjects) (%) IDH mutation only 45 Triple-positive [TERTp-mut, IDH-mut, 1p/19q codeletion] 29 TERTp-mutation only 10 Triple negative [TERTp- wild type, IDH-wild type, 1p/19q…

read more

Introduction: From the Inhibition of Dogmas to the Concept of Personalized Management in Patients with Diffuse Low-Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on Introduction: From the Inhibition of Dogmas to the Concept of Personalized Management in Patients with Diffuse Low-Grade Gliomas

© Springer-Verlag London Ltd. 2017Hugues Duffau (ed.)Diffuse Low-Grade Gliomas in Adults10.1007/978-3-319-55466-2_1 1. Introduction: From the Inhibition of Dogmas to the Concept of Personalized Management in Patients with Diffuse Low-Grade Gliomas Hugues Duffau1, 2   (1) Department…

read more

Pathogenesis of Diffuse Low-Grade Gliomas

Oct 25, 2017 by in ONCOLOGY Comments Off on Pathogenesis of Diffuse Low-Grade Gliomas

  Type-1 Type-2 Type-3a Type-3b Clinical characteristics  Age, median (IQR), y 45 (36–54) 36 (30–44) 43 (28–49) 57 (46–64)  OS, mean (95% CI), y 16.38 (14.15–NA) 7.88 (6.76–9.70) 9.13 (5.05–NA)…

read more

Minimally Invasive Surgery for Endometrial Cancer

Oct 25, 2017 by in ONCOLOGY Comments Off on Minimally Invasive Surgery for Endometrial Cancer

Fig. 7.1 Surgeon’s console Fig. 7.2 Patient cart Robotic surgery enables surgeons to be more precise, advancing their technique and enhancing their capability in performing complex minimally invasive surgery. Binocular…

read more

Diagnosis and Pre-management Workup of Endometrial Carcinoma

Oct 25, 2017 by in ONCOLOGY Comments Off on Diagnosis and Pre-management Workup of Endometrial Carcinoma

Fig. 5.1 Tamoxifen-induced cystic hyperplasia of the endometrium Hence, in asymptomatic women, there is a poor correlation between ultrasonographically measured endometrial thickness and abnormal pathology, and screening them has not…

read more
Get Clinical Tree app for offline access